US Stock MarketDetailed Quotes
CPHI China Pharma
- 0.3136
- -0.0039-1.21%
Trading Apr 23 15:07 ET
4.65MMarket Cap-344P/E (TTM)
0.3249High0.3064Low160.49KVolume0.3179Open0.3175Pre Close50.37KTurnover2.86%Turnover RatioLossP/E (Static)14.82MShares2.695052wk High0.62P/B1.76MFloat Cap0.302552wk Low--Dividend TTM5.60MShs Float2044.2703Historical High--Div YieldTTM5.83%Amplitude0.3020Historical Low0.3130Avg Price1Lot Size
China Pharma Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -8.26%1.8M | -31.94%1.1M | 22.21%1.96M | -15.95%8.1M | 1.09%2.92M | -0.64%1.97M | -33.22%1.61M | -31.99%1.6M | -11.27%9.64M | -1.42%2.89M |
| Operating revenue | -8.26%1.8M | -31.94%1.1M | 22.21%1.96M | -15.95%8.1M | 1.09%2.92M | -0.64%1.97M | -33.22%1.61M | -31.99%1.6M | -11.27%9.64M | -1.42%2.89M |
| Cost of revenue | -3.19%2.04M | -32.46%1.24M | 0.50%1.78M | -7.48%8.6M | 11.24%2.88M | -7.53%2.1M | -21.41%1.84M | -14.97%1.77M | 4.25%9.29M | 9.19%2.59M |
| Gross profit | -69.28%-233.19K | 36.06%-146.66K | 204.99%177.92K | -241.41%-493.92K | -85.86%42.68K | 53.52%-137.76K | -423.07%-229.38K | -162.14%-169.46K | -82.12%349.27K | -46.22%301.94K |
| Operating expense | -20.20%498.56K | -44.89%305.6K | -21.71%585.44K | -9.12%3.15M | 1.71%1.22M | 36.51%624.73K | -33.08%554.57K | -23.49%747.78K | -21.54%3.46M | -24.45%1.2M |
| Selling and administrative expenses | -15.52%452.79K | -47.76%281.85K | -18.93%562.43K | -5.82%2.96M | 4.06%1.19M | 22.86%535.99K | -30.41%539.51K | -11.89%693.73K | -22.09%3.15M | -13.66%1.15M |
| -Selling and marketing expense | -20.38%206.52K | -36.27%169.82K | -19.56%144.43K | -28.44%1.07M | -32.13%364.4K | 93.14%259.38K | -40.19%266.45K | -52.54%179.56K | -32.52%1.5M | 5.78%536.9K |
| -General and administrative expense | -10.97%246.27K | -58.97%112.03K | -18.70%418K | 14.67%1.89M | 35.91%829.43K | -8.40%276.61K | -17.20%273.06K | 25.71%514.17K | -9.42%1.65M | -25.67%610.3K |
| Research and development costs | -48.42%45.77K | 57.65%23.75K | -57.43%23.01K | -41.73%185.86K | -48.20%28K | 315.21%88.75K | -71.82%15.06K | -71.57%54.05K | -15.61%318.96K | -79.33%54.05K |
| Operating profit | 4.03%-731.75K | 42.31%-452.26K | 55.57%-407.52K | -16.92%-3.64M | -31.12%-1.18M | -1.12%-762.49K | -3.47%-783.95K | -30.16%-917.24K | -26.50%-3.12M | 12.57%-899.31K |
| Net non-operating interest income expense | 37.27%-64.06K | -25.66%-136.72K | 33.35%-78.5K | 21.36%-423.86K | 71.34%-95.17K | -58.90%-102.12K | -51.51%-108.8K | -66.21%-117.77K | -86.83%-538.97K | -208.77%-332.03K |
| Non-operating interest income | 17.50%2.18K | -24.03%942 | -85.76%948 | 254.37%10.76K | -28.97%1K | 191.07%1.86K | 114.16%1.24K | 1,539.16%6.66K | -46.52%3.04K | 242.72%1.41K |
| Non-operating interest expense | -36.29%66.24K | 25.10%137.66K | -36.15%79.45K | -19.81%434.62K | -71.16%96.18K | 60.20%103.98K | 52.01%110.04K | 74.60%124.43K | 84.25%542K | 208.90%333.44K |
| Other net income (expense) | -75.33%18.21K | -192.86%-4.05K | 81.78%10.04K | -63.23%93.85K | -95.96%10.14K | 981.94%73.84K | -8.14%4.36K | -32.84%5.52K | 321.57%255.22K | 443.92%250.62K |
| Special income (charges) | -75.33%18.21K | -192.86%-4.05K | 81.78%10.04K | -63.23%93.85K | -95.96%10.14K | 981.94%73.84K | -8.14%4.36K | -32.84%5.52K | 321.57%255.22K | 443.92%250.62K |
| -Write off | 75.33%-18.21K | 192.86%4.05K | -81.78%-10.04K | 63.23%-93.85K | 95.96%-10.14K | -981.94%-73.84K | 8.14%-4.36K | 32.84%-5.52K | -321.57%-255.22K | -443.92%-250.62K |
| Income before tax | 1.67%-777.6K | 33.25%-593.03K | 53.77%-475.98K | -16.87%-3.97M | -28.90%-1.26M | 4.34%-790.77K | -7.72%-888.39K | -34.17%-1.03M | -18.58%-3.4M | 18.88%-980.72K |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | 1.67%-777.6K | 33.25%-593.03K | 53.77%-475.98K | -16.87%-3.97M | -28.90%-1.26M | 4.34%-790.77K | -7.72%-888.39K | -34.17%-1.03M | -18.58%-3.4M | 18.88%-980.72K |
| Net income continuous Operations | 1.67%-777.6K | 33.25%-593.03K | 53.77%-475.98K | -16.87%-3.97M | -28.90%-1.26M | 4.34%-790.77K | -7.72%-888.39K | -34.17%-1.03M | -18.58%-3.4M | 18.88%-980.72K |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 1.67%-777.6K | 33.25%-593.03K | 53.77%-475.98K | -16.87%-3.97M | -28.90%-1.26M | 4.34%-790.77K | -7.72%-888.39K | -34.17%-1.03M | -18.58%-3.4M | 18.88%-980.72K |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 1.67%-777.6K | 33.25%-593.03K | 53.77%-475.98K | -16.87%-3.97M | -28.90%-1.26M | 4.34%-790.77K | -7.72%-888.39K | -34.17%-1.03M | -18.58%-3.4M | 18.88%-980.72K |
| Basic earnings per share | 62.50%-0.3 | 66.67%-0.3 | 72.73%-0.3 | -2.70%-3.8 | 16.67%-1 | 20.00%-0.8 | 10.00%-0.9 | -10.00%-1.1 | -5.71%-3.7 | 20.00%-1.2 |
| Diluted earnings per share | 62.50%-0.3 | 66.67%-0.3 | 72.73%-0.3 | -2.70%-3.8 | 16.67%-1 | 20.00%-0.8 | 10.00%-0.9 | -10.00%-1.1 | -5.71%-3.7 | 20.00%-1.2 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg